Citius Oncology, Inc. CTOR Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$26.61M-381% | -$5.53M-10.8% | -$5M+7.0% | -$5.37M+30.6% | -$7.74M-16.2% | ||
| $3.53M-10.9% | $3.96M+72.1% | $2.3M+8.1% | $2.13M+1.8% | $2.09M+15.5% | ||
| —— | $264.24K0.0% | $264.24K0.0% | $264.24K0.0% | $264.24K0.0% | ||
| —— | $4.05M— | —— | —— | —— | ||
| $20.25K-94.3% | $352.65K-90.5% | $3.71M+98.4% | $1.87M+95.2% | $957.88K-84.3% | ||
| -$1.56M+43.9% | -$2.79M-161% | $4.57M+361% | $991.11K-45.0% | $1.8M-16.7% | ||
| $19.54M+4,489% | $425.79K— | —— | —— | $2.49M-60.0% | ||
| —— | $1.83M— | —— | —— | —— | ||
| -$3.83M+47.9% | -$7.35M-436% | -$1.37M0.0% | -$1.37M0.0% | -$1.37M0.0% | ||
| $600K-86.4% | $4.4M+206% | $1.44M0.0% | $1.44M0.0% | $1.44M0.0% | ||
| —— | $40M+2,393% | $1.6M0.0% | $1.6M0.0% | $1.6M0.0% | ||
| -$600K+86.4% | -$4.4M-206% | -$1.44M0.0% | -$1.44M0.0% | -$1.44M0.0% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | $20M— | —— | —— | ||
| —— | $15.13M-0.3% | $15.17M— | —— | —— | ||
| —— | $15.13M+299% | $3.79M0.0% | $3.79M0.0% | $3.79M0.0% | ||
| -$4.66M-238% | $3.37M+244% | $981.2K0.0% | $981.2K0.0% | $981.2K0.0% | ||
| —— | $14.46K-69.1% | $46.85K0.0% | $46.85K0.0% | $46.85K0.0% | ||
| $1.72M+200% | $573.44K— | —— | —— | —— | ||
| -$1.56M+43.9% | -$2.79M-161% | $4.57M+361% | $991.11K-45.0% | $1.8M-16.7% | ||
| -$3.27M-265% | $1.98M-3.3% | $2.05M-18.8% | $2.52M+23.3% | $2.05M-11.4% | ||
| —— | $1.83M— | —— | —— | —— | ||
| —— | $2.75M— | —— | —— | —— | ||
| —— | $40M— | —— | —— | —— | ||
| $600K-86.4% | $4.4M+206% | $1.44M0.0% | $1.44M0.0% | $1.44M0.0% | ||
| —— | —— | $20M— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $328.88K-58.3% | $789.21K— | —— | —— | —— | ||
| -$0.27-350% | -$0.060.0% | -$0.06+25.0% | -$0.08+27.3% | -$0.11-22.2% | ||
| —— | —— | 6.3%— | —— | —— | ||
| $1.76M— | —— | —— | —— | —— | ||
| $23.63M+726% | $2.86M+114% | $1.34M-28.9% | $1.88M-16.1% | $2.24M-32.5% | ||
| $1.34M-57.6% | $3.15M— | —— | —— | —— | ||
| -$26.84M-409% | -$5.27M-11.4% | -$4.73M+7.3% | -$5.11M+31.7% | -$7.47M-16.8% | ||
| —— | —— | $54.51K0.0% | $54.51K0.0% | $54.51K0.0% | ||
| $33.03K-27.9% | $45.84K-20.0% | $57.28K-64.4% | $160.76K— | —— | ||
| $43.72K+54.6% | $28.29K+211% | $9.09K0.0% | $9.09K0.0% | $9.09K0.0% | ||
| $1.77M+10,199% | -$17.55K+61.3% | -$45.41K0.0% | -$45.41K0.0% | -$45.41K0.0% | ||
| $27.94K0.0% | $27.94K0.0% | $27.94K0.0% | $27.94K-8.0% | $30.37K0.0% | ||
| $469K-2.3% | $480K0.0% | $480K0.0% | $480K0.0% | $480K0.0% | ||
| —— | —— | —— | —— | —— | ||
| $1.67M-57.7% | $3.94M— | —— | —— | —— | ||
| —— | —— | 85%— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | 0%— | —— | —— | ||
| —— | —— | 11.6M— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | $342.18K0.0% | $342.18K0.0% | $342.18K0.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Citius Oncology, Inc. generate?
- Citius Oncology, Inc. (CTOR) generated -$13.9M in operating cash flow over the trailing twelve months.
- Where does Citius Oncology, Inc.'s cash flow data come from?
- Every line is extracted from Citius Oncology, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.